NEWS
![the panelists and host in video chat on a black background](/sites/default/files/styles/front_page_card/public/2022-06/COVID%20panel%20comp%20leaderboard.png?itok=qQk9BvIz)
Panel discussion spotlights COVID-19 R&D
The Data Science Institute's career panel series continued on June 28 with a discussion of LLNL’s COVID-19 research and development. Four data scientists talked about their work in drug screening, protein–drug compounds, antibody–antigen sequence analysis, and risk factor identification.
![image of cartoon people assembling puzzle pieces superimposed over a photo in which students and mentors stand as a group](/sites/default/files/styles/front_page_card/public/2022-07/uc-merced-dsc-comp-news.png?itok=fo1lbdgh)
UC Merced students work with LLNL mentors on potential new drugs to combat COVID-19
For the first time in the DSC series since the COVID-19 pandemic began in 2020, Lab mentors visited the college campus to provide in-person guidance for five teams of UC Merced students.
![drawing of cars on a road with teal concentric circles radiating out of them](/sites/default/files/styles/front_page_card/public/2022-06/assured-ml-comp-leaderboard.png?itok=Os3sD4VU)
Assured and robust…or bust
Livermore’s machine learning experts aim to provide assurances on performance and enable trust in machine-learning technology through innovative validation and verification techniques.